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ABSTRACT
Specific cleavage of large DNA molecules at few
sites, necessary for the analysis of genomic DNA or
for targeting individual genes in complex genomes,
requiresendonucleasesofextremelyhighspecificity.
Restriction endonucleases (REase) that recognize
DNA sequences of 4–8 bp are not sufficiently specific
forthispurpose.Inprinciple,thespecificityofREases
can be extended by fusion to sequence recognition
modules, e.g. specific DNA-binding domains or
triple-helix forming oligonucleotides (TFO). We have
chosen to extend the specificity of REases using
TFOs, given the combinatorial flexibility this fusion
offers in addressing a short, yet precisely recognized
restriction site next to a defined triple-helix forming
site (TFS). We demonstrate here that the single chain
variant of PvuII (scPvuII) covalently coupled via the
bifunctional cross-linker N-(g-maleimidobutryloxy)
succinimide ester to a TFO (50-NH2-[CH2]6o r1 2 -MPM-
PMPMPMPPPPPPT-30, with M being 5-methyl-
20-deoxycytidine and P being 5-[1-propynyl]-20-
deoxyuridine), cleaves DNA specifically at the recog-
nition site of PvuII (CAGCTG) if located in a distance
of approximately one helical turn to a TFS (under-
lined) complementary to the TFO (‘addressed’ site:
50-TTTTTTTCTCTCTCTCN 10CAGCTG-30), leaving
‘unaddressed’ PvuII sites intact. The preference for
cleavage of an ‘addressed’ compared to an ‘unad-
dressed’ site is .1000-fold, if the cleavage reaction
is initiated by addition of Mg
21 ions after preincuba-
tion of scPvuII-TFO and substrate in the absence of
Mg
21 ions to allow triple-helix formation before DNA
cleavage. Single base pair substitutions in the TFS
prevent addressed DNA cleavage by scPvuII-TFO.
INTRODUCTION
The development of artiﬁcial or semisynthetic nucleases
capable of highly speciﬁc cleavage of any desired sequence
would greatly facilitate physical mapping and manipulation
of genomes as well as targeting genes in vivo. Strategies
for generating such programmable nucleases include the
coupling of DNA-binding domains (1–5) or triple-helix form-
ing oligonucleotides (TFOs) (6–8) to non-speciﬁc nucleases or
‘chemical’ nucleases. An inherent disadvantage of using non-
speciﬁc nucleases of natural or chemical origin, however, is
that they do not cleave the DNA at a deﬁned phosphodiester
bond but rather produce DNA fragments with heterogeneous
ends. In this respect, Type II restriction endonucleases
(REase), though not yet exploited for this purpose, appear
superior to non-speciﬁc nucleases for the development of a
programmable nuclease, because REases cleave DNA at spe-
ciﬁc sites, 4–8 bp in length, leaving deﬁned ends [review: (9)].
REases are very accurate enzymes: the ratio of activities at
cognate and non-cognate sites is very large; e.g. in pAT153
EcoRV cleaves it canonical site (GATATC) by a factor of
10
6 faster than the next best site (GTTATC) [review: (10)].
Almost all restriction enzymes require Mg
2+ ions for phos-
phodiester bond cleavage [reviews: (11,12)]. In some cases,
e.g. EcoRV, Mg
2+ ions or other divalent metal ions, such as
Ca
2+ ions, are required also for speciﬁc DNA-binding (13,14).
A REase–TFO conjugate would have a bipartite recognition
sequence, consisting of the recognition site of the REase and
the DNA sequence matching to the TFO (Figure 1). DNA
triple helices are formed by the binding of synthetic oligonu-
cleotides within the major groove of duplex DNA, where they
make speciﬁc hydrogen bond contacts with the Hoogsteen
faces of the purine bases [reviews: (15–17)]. Polypyrimidine
TFOs bind in parallel orientation, polypurine TFOs in an
antiparallel with respect to the duplex purine strand. The par-
allel motif has been most widely studied and is characterized
by the formation of C
+.GC and T.AT triplets (the notation
X.ZY refers to a triplet, in which the third strand base X
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doi:10.1093/nar/gki1009interacts with the duplex ZY base pair, forming hydrogen
bonds to base Z). Recent work has demonstrated that by
using a combination of nucleoside analogs it is possible to
generate stable triplexes with high sequence speciﬁcity
at physiological pH even to target sites not consisting of
homopurine tracts (18–22).
We have produced a conjugate of a PvuII variant (23) and
a TFO containing modiﬁed bases (19) using a bifunctional
cross-linker. This REase–TFO conjugate has a bipartite recog-
nition sequence consisting of the PvuII recognition site
(CAGCTG) and the double-stranded (ds) DNA sequence (50-
TTTTTTTCTCTCTCTC-30/50-GAGAGAGAGAAAAAAA-30)
addressed by the TFO. We demonstrate here that at neutral
pH and Mg
2+ concentrations of 1–2 mM, this REase-TFO
cleaves DNA speciﬁcally at the bipartite recognition sequence
(addressed PvuII sites), leaving unaddressed PvuII sites
intact. This speciﬁcity, in principle, sufﬁces to target a unique
sequence in a genomic context.
MATERIALS AND METHODS
Proteins and oligonucleotides
The mutant coding for the His6-tagged single cysteine variant
scPvuII-H6G4C was generated using pRIZ’-scPvuII (23) as
template by a PCR-based site-directed mutagenesis method
(24); the protein was expressed and puriﬁed similarly as
described previously (25). TFOs containing a 50-C6-spacer
or 50-C12-spacer with a N-terminal group were purchased form
Eurogentec: 50-NH2-[CH2]6/12-MPMPMPMPMPPPPPPT-30,
where M is 5-methyl-20-deoxycytidine and P is 5-[1-propynyl]-
20-deoxyuridine (19,26).
Fluorescence anisotropy measurements
To demonstrate that the single chain variant of PvuII (scPvuII)
variant which we used required divalent cations for strong
DNA-binding, ﬂuorescence titrations were carried out with
Figure 1. Generalstrategyto generatea programmedrestrictionenzyme.ThesinglechainvariantofPvuIIis covalentlylinkedviaa (CH2)6-or(CH2)12 -linkertoa
TFOusingGMBS,abifunctionalchemicalcross-linkerspecificforaminoandsulfhydrylgroups.Thefinalconstructs,scPvuII-C6-TFOandscPvuII-C12-TFO,havea
bipartite recognition site: the PvuII recognition site and the TFS.
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(hybridized to its non-labeled complement) at various concen-
trations and scPvuII-H6G4C (0–450 nM) in 50 mM Tris–HCl
(pH 7.5), 100 mM NaCl in the presence of 10 mM Ca
2+ or
3 mM EDTA, respectively, at 23 C in a F-4500 Hitachi ﬂuo-
rimeter), similarly as described by Reid et al. (27).
Electrophoretic mobility shift assay (EMSA)
To demonstrate the high stability of the triple-helix used in our
experiments EMSAs were performed with the TFO and a
complementary double-stranded oligodeoxyribonucleotide.
The TFO (5–500 nM) was incubated at 37 C for 1 h with
32P-labeled double-stranded 50-TTTTTTTCTCTCTCTC-30/
50-GAGAGAGAGAAAAAAA-30 (50 nM) in 10 mM Tris–
phosphate (pH 7.2), 1 mM spermine in a volume of 15 ml.
Subsequently, 5 ml of 10 mM Tris–phosphate (pH 7.2), 25%
(w/v) sucrose were added to each sample and complex forma-
tion was analyzed by electrophoresis on 15% polyacrylamide
gels in 10 mM Tris–phosphate (pH 7.2). Gels were dried
and the radioactive bands visualized using an instant imager
(Canberra Packard).
Restriction enzyme cleavage protection assay
Cleavage protection assays were performed with a 150 bp
DNA substrate containing a FokI site and an adjacent
triple-helix forming site (TFS) overlapping the cleavage site
of FokI. Substrate (1 mM) was preincubated in 10 mM Tris–
phosphate (pH 7.2) with either 10 mM TFO or a non-speciﬁc
hexadecadeoxyribonucleotide for 4 h at 37 C in a volume of
70 ml. Forty units FokI (NEB) (in FokI cleavage buffer) were
added to give a ﬁnal volume of 100 ml. At selected time points
(0.5,1, 1.5, 2,5, 10, 20,30, 45 and60 min),10 mlaliquots were
withdrawn and the reaction terminated by adding EDTA
(50 mM ﬁnal concentration). Loading buffer (5 ml) [10%
(w/v) Ficoll, 10% (v/v) glycerol, 0.2% (w/v) bromphenol
blue and 0.2% (w/v) xylene cyanol] were then added and
cleavage protection was analyzed by electrophoresis on 12%
polyacrylamide gels in 80 mM Tris–phosphate (pH 8.2) and
2 mM EDTA. Products were visualized by ethidium bromide
(0.1 mg/ml) staining and illumination with UV light.
Protein-TFO cross-linking
For activation of the oligonucleotide, 80 mM TFO was
incubated with 40 mM bifunctional cross-linker N-(g-
maleimidobutryloxy) succinimide ester (GMBS, Pierce) in
500 ml phosphate-buffered saline (PBS) [140 mM NaCl,
2.7 mM KCl, 4.3 mM Na2HPO4 and 1.4 mM K2HPO4
(pH 7.2)] for 1 h at 23 C. Unreacted cross-linker was removed
by passage through NAP -5 and subsequently NAP -10
(Amersham Sephadex  G-25 DNA grade) equilibrated
with water. The desalted, activated TFO was dried and dis-
solved in 80 ml PBS. For cross-linking of oligonucleotide and
protein, 80 mM activated TFO was incubated for 1 h at 23 C
with 20 mM scPvuII-H6G4C, which had been dialyzed for 4 h
against PBS to remove DTT. Cross-linking yield was analyzed
by 15% SDS–PAGE.
Protein-TFO purification
Uncross-linked scPvuII-H6G4C was separated from cross-
linkedscPvuII-C6/C12-TFObyanionexchangechromatography
using DE52 in 10 mM Tris–HCl (pH 7.5), 3 mM EDTA using
a linear gradient of NaCl (100–400 mM). scPvuII-H6G4C
eluted in the ﬂow through whereas scPvuIIC6/C12-TFO
eluted at a concentration of 350–390 mM–NaCl. Puriﬁed
scPvuII-C6/C12-TFO was dialyzed against PBS containing
25% PEG 10000 and then stored at 4 C.
DNA cleavage assays
For DNA cleavage experiments, radioactively labeled 239 bp
substrates (containing a single PvuII site) were generated
by PCR using [a-
32P]dATP. All substrates share the same
sequence except for that replaced by the TFS (only the pyrimi-
dine rich strand is shown, underlined) adjacent to the PvuII
site (bold): 3 bp, 50-...CGGTACTCGACGTTTTTTTCT-
CTCTCTCAGACAGCTG...-30;5b p ,5 0-...CGGTACTC-
GATTTTTTTCTCTCTCTCGCAGACAGCTG...-30; 7 bp,
50-...CGGTACTCTTTTTTTCTCTCTCTCCAGCAGACA-
GCTG...-30;9bp,5 0-...CGGTACTTTTTTTCTCTCTCTC-
CACAGCAGACAGCTG...-30;1 1b p ,5 0-...CGGTTTTTT-
TTCTCTCTCTCCGCACAGCAGACAGCTG...-30; 13 bp,
50-... CGTTTTTTTCTCTCTCTCGGCGCACAGCAGA-
CAGCTG... -30.
For control reaction an unaddressed 478 bp substrate that
contains the same central sequence as the 239mer with the
exceptionthat itdoes notcarrya TFSwas generatedby PCRas
well. All substrates were puriﬁed using the QIAquick PCR
Puriﬁcation Kit (Qiagen) and analyzed by PAGE. Concentra-
tions were calculated assuming 50 ng/ml DNA corresponds to
an OD260 of 1. To analyze DNA cleavage, 45 nM of these
substrates were cleaved by 5 nM scPvuII-C6/C12-TFO at 37 C
in 10 mM Tris–phosphate (pH 7.2), 10 mM MgCl2,1m M
spermine. Reactions were terminated after 5, 10, 20, 30, 60
or 110 min by addition of EDTA to a ﬁnal concentration of
50 mM. Reaction products were analyzed by electrophoresis
on 12% polyacrylamide gels. Gels were dried and the radio-
active bands visualized by autoradiography using an instant
imager system (Canberra Packard). To analyze targeted
cleavage, 40 nM scPvuII-C6/C12-TFO was preincubated with
addressed and unaddressed substrate in competition (each at
45 nM) in 10 mM Tris–phosphate (pH 7.2), 1 mM spermine,
3 mM EGTA at 23 C overnight. EGTA was included in the
preincubation buffer to chelate divalent metal ions that even at
low concentrations would have stimulated speciﬁc binding to
the PvuII site of the unaddressed substrate. Cleavage reactions
were initiated at 37 C by adding an equal volume of 10 mM
Tris–HCl (pH 7.2) with MgCl2 to various ﬁnal concentrations:
1.25, 2.5 or 5 mM. Cleavage products were analyzed as
described above. Similar experiments were done with variants
of the 239 bp substrate, which carry a modiﬁed TFS,
50-TTTTTTTYTCTCTCTC-30 (Y ¼ A, G or T)/50-GAGA-
GAGAXAAAAAAA-30 (X ¼ T, C or A), in a distance of
9 bp to the PvuII site. To analyze targeted cleavage of larger
substrates by scPvuII-C12-TFO, a 5556 bp plasmid with 5
PvuII sites, one of which is adjacent to a TFS, was used.
Preincubation and cleavage of the supercoiled and HindIII-
linearized plasmid were done as described for the 239 and
478 bp substrates. Cleavage products were separated by elec-
trophoresis on 0.8% agarose gels that were subsequently
stained with SYBR gold and analyzed using the Biometra
software. A similar plasmid cleavage experiment was carried
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l-DNA (0.007 pmol plasmid DNA with a single addressed
PvuII site and 3 PvuII sites, 0.68 pmol l-DNA with 15 PvuII
sites, 0.006 pmol scPvuII-C12-TFO, preincubated in the
absence of Mg
2+ for 72 h at 23 C; cleavage was initiated
by addition of MgCl2 and NaCl to give a ﬁnal concentration
of 2.5 mM MgCl2 and 100 mM NaCl).
RESULTS
To generate a programmed restriction enzyme we coupled
a single chain variant of PvuII with a TFO (Figure 1).
PvuII is a homodimeric Type II REase (9,11) that recognizes
the double-stranded DNA sequence CAG/CTG, cleaving it
as indicated (28,29). It is one of the best studied restriction
enzymes, both in terms of structure (30–32) and function (33).
PvuII requires Mg
2+ for both speciﬁc DNA-binding and DNA
cleavage (33,34).
We used the monomeric scPvuII (23) as the fusion partner
to generate a programmable restriction enzyme as this allowed
us to introduce a unique single cysteine for the coupling of
the TFO. To this end, a His6-tag followed by four glycines
and one cysteine residue was added to the C-terminus of
scPvuII. This variant binds speciﬁc DNA in the presence of
Ca
2+ (as an analogue of Mg
2+) with 27 nM afﬁnity, and with
20 mM afﬁnity in its absence, as shown by ﬂuorescence
anisotropy measurements (data not shown).
TFOs bind via Hoogsteen hydrogen bonds in the major
groove of the DNA, either in a parallel (pyrimidine motif,
Y.RY) or antiparallel (purine motif, R.YR) orientation with
respect to the purine strand of the Watson–Crick base pairs
(35). Repulsion of the negatively charged DNA strands can be
overcome by adding spermine (36). Pyrimidine motif triple
helicesareunstableatphysiologicalpHbecauseoftherequire-
ment for cytosine protonation that occurs at relatively acidic
pH (pKa ¼ 4.5) (37,38). With 5-methylcytosine (M) replacing
cytosine, this pH restriction is reduced via the contribution of
the methyl group to base stacking and the exclusion of water
from the major groove of the DNA (39). Using propynyl-
deoxyuridine (P) instead of thymine also increases triple-
helix stability (19,40). For this study, we utilized the TFO
50-NH2-[CH2]6/12-MPMPMPMPMPPPPPPT-30. Triple-helix
formation between this TFO and a complementary double-
stranded hexadecadeoxyribonucleotide or a 150 bp PCR prod-
uct containing the TFS (TFS: 50-TTTTTTTCTCTCTCTC-30/
50-GAGAGAGAGAAAAAAA-30) was demonstrated by
EMSA and restriction cleavage protection assay. A binding
constant of KAss ¼ 6.4 · 10
7 M
 1 was determined for the
TFO and the double-stranded DNA by electrophoretic
mobility shift experiments (data not shown).
The TFO was coupled with the bifunctional cross-linker
GMBS (N-[g-maleimidobutyryloxy]succinimide ester) via
amide bond formation between the 50-NH2-group of the TFO
and the succinimide group of GMBS. The NH2-group is con-
nected to the TFO by 6 or 12 methylene groups, resulting
in different linker lengths in the ﬁnal scPvuII-C6-TFO or
scPvuII-C12–TFO conjugates, respectively. The maleimide
group of the GMBS-modiﬁed TFO reacts with the single cys-
teine at the C-terminal end of the scPvuII-H6G4C variant to
create a covalent scPvuII-C6/C12-TFO conjugate. Coupling
yields exceeded 70%. Residual amounts of uncross-
linked scPvuII-H6G4C were removed by anion exchange
chromatography.
Activity and speciﬁcity of scPvuII-C6/C12-TFO were tested
with DNA substrates of similar sequence generated by PCR:
(i) a 239 bp substrate with a TFS adjacent to a PvuII site
(‘addressed’ DNA substrate) and; (ii) a 478 bp substrate
that incorporates the 239 bp substrate sequence but does
not have a TFS adjacent to its PvuII site (‘unaddressed’
DNA substrate). In PvuII cleavage buffer, scPvuII-C6/C12-
TFO exhibits the same cleavage activity with both substrates,
demonstrating that the presence of the TFS next to the PvuII
site does not inﬂuence DNA cleavage under conditions where
triple-helix formation does not take place (data not shown).
In targeted DNA cleavage experiments, the TFO of
scPvuII-C6/C12-TFO should guide the enzyme to the PvuII
site adjacent to the TFS. Since the kinetics of triplex formation
are slow, these experiments require a preincubation of the
DNA with the scPvuII-C6/C12-TFO conjugate. Initial experi-
ments were carried out with scPvuII-C12-TFO. Targeting was
investigated by cleaving the 239 bp substrate (with the TFS at
a distance of 9 bp from the PvuII site) and the 478 bp substrate
(without the TFS) in competition: scPvuII-C12-TFO was prein-
cubated overnight with DNA substrates in a buffer compatible
with triple-helix formation and depleted of divalent metal ions
to prevent binding to PvuII sites without the adjacent TFS.
Preincubation was carried out using near equimolar amounts
of scPvuII-C12-TFO and addressed DNA substrate to obtain
near stoichiometric binding of the TFS and avoid excess free
enzyme in the reaction mixture. Cleavage was initiated by
adding PvuII cleavage buffer with MgCl2 at different ﬁnal
concentrations: 1.25, 2.5 or 5 mM. As shown in Figure 2
we observed a very strong cleavage preference of
scPvuII-C6/C12-TFO for the addressed substrate. This prefer-
ence showed a clear MgCl2 concentration dependence: with
decreasing concentration of MgCl2 the rate of cleavage of the
unaddressed 478 bp substrate was reduced, approaching zero
at 1.25 mM MgCl2, whereas the rate of cleavage of the
addressed 239 bp substrate was not changed (Figure 2).
This dependence of the cleavage rates on the Mg
2+ concen-
tration can be understood by considering that DNA-binding
and cleavage by PvuII requires Mg
2+ (34,41). In the case of
addressed cleavage the enzyme is Mg
2+ ion-independently
bound to its cleavage site via the TFO–TFS interaction, allow-
ing efﬁcient cleavage even at low Mg
2+ concentrations that
would not readily support unaddressed cleavage. Total
addressed substrate was not cleaved to completion since a
substoichiometric amount of scPvuII-C12-TFO was used
(40 nM enzyme versus 45 nM of each substrate). Experiments
in 1.25 mM MgCl2 with different enzyme concentrations con-
ﬁrmed that moles of substrate cleaved correspond exactly to
moles of enzyme used, demonstrating that the enzyme does
not turnover but remains bound to one of the products via
triple-helix formation. With an excess of enzyme over
DNA the unaddressed substrate is also cleaved, albeit at a
much slower rate (data not shown).
In the experiment described above, the PvuII site and the
TFS on the addressed 239 bp substrate were separated by 9 bp.
Since it is likely that the distance between the PvuII site and
the TFS inﬂuences the efﬁciency of cleavage, we prepared
additional addressed 239 bp substrates having 3, 5, 7, 11 or
7042 Nucleic Acids Research, 2005, Vol. 33, No. 2213bpdistances.Furthermore,toinvestigate whetherthe length
of the linker between scPvuII and the TFO has an effect on
the addressed cleavage or optimum distance between the
PvuII site and the TFS, two conjugates, scPvuII-C12–TFO
(12 methylene groups) and scPvuII-C6-TFO (six methylene
groups), were prepared and analyzed. Cleavage reactions
were carried out using addressed and unaddressed substrate
in competition. Cleavage rates of the unaddressed substrates
are extremely low in all reactions initiated with 1.25 mM
MgCl2: the rate constants for cleavage of the unaddressed
substrate by scPvuII-C12-TFO and scPvuII-C6-TFO were
kunaddressed(C12) ¼ 0.002 min
 1 and kunaddressed(C6) ¼
0.001 min
 1, respectively. Up to 1400-fold higher cleavage
rates were observed for the addressed substrate, with the best
substrates having a 9 or 11 bp distance between the PvuII site
and the TFS. For scPvuII-C12-TFO, the DNA having a 13 bp
distance between the PvuII site and the TFS was also a very
good substrate. Cleavage rates observed for scPvuII-C12-TFO
were higher than for scPvuII-c6-TFO, presumably due to
the greater ﬂexibility of the C12-linker. Cleavage rates of
substrates with PvuII site and TFS distances shorter than
7 bp decreased, with scPvuII-C6-TFO more so that with the
scPvuII-C12-TFO, again indicating a higher ﬂexibility of the
C12-linker (Table 1). We assume, that both the C-terminal
extension H6G4C of scPvuII and the 50-NH2-[CH2]6/12-
extension of the TFO are needed for the simultaneous binding
of the PvuII recognition sequence and the adjacent TFS by
the scPvuII–TFO conjugate. Our data suggest that the
C12-linker is superior to the C6-linker in this respect.
In the presence of 2.5 mM MgCl2 (data not shown) or 5 mM
MgCl2 (Figure 2), cleavage preferences are smaller because
cleavage of the unaddressed substrate is faster. The decreased
cleavage preference at 2.5 mM MgCl2 concentration can be
compensated by addition of NaCl at concentrations up to
100 mM (data not shown). Presumably, low Mg
2+ concentra-
tions are needed for preferential cleavage at addressed sites,
because at higher Mg
2+ concentrations DNA-binding by the
scPvuII–TFO conjugate is dominated by the protein–DNA
interaction and not the TFO–TFS interaction.
To demonstrate addressed cleavage of larger DNA mole-
cules, a 5556 bp plasmid with ﬁve PvuII sites, one having a
TFS at a distance of 9 bp, was used (Figure 3). Cleavage of the
supercoiled plasmid with PvuII or scPvuII-C12-TFO without
preincubation resulted in ﬁve cleavage fragments. However,
after preincubation of near stoichiometric amounts of
scPvuII-C12-TFO and the plasmid, only one cleavage product,
Figure 2. UnaddressedversusaddressedDNAcleavagebyscPvuII-C12-TFOat
two Mg
2+ concentrations. Equimolar (45 nM) amounts of unaddressed 478 bp
substrate (diamond; no TFS) and addressed 239 bp substrate (square; having a
TFS 9 bp away from the PvuII site) were mixed and preincubated with
scPvuII-C12-TFO (40 nM) to allow triple-helix formation. After addition of
1.25 mM (top) or 5 mM (bottom) MgCl2, the kinetics of cleavage were deter-
mined. Whereas at 5 mM MgCl2 the unaddressed substrate is cleaved with
appreciable rate, it is not cleaved to a significant extent in the presence of
1.25mMMgCl2.Incontrast,theaddressedsubstrateiscleavedwitha highrate
in the presence of either 1.25 (top) or 5 mM MgCl2 (bottom). P denotes the
unaddressed PvuII site. The addressed PvuII site is indicated by an open star.
Table 1. Rate constants for cleavage by scPvuII-C6/C12-TFO of the 239 bp substrates
Distance between
TFS and PvuII site
kaddressed (scPvuII-C12-TFO) Cleavage preference
(scPvuII-C12-TFO)
kaddressed (scPvuII-C6-TFO) Cleavage preference
(scPvuII-C6-TFO)
3 bp 1.0 min
 1 (±5%) 440-fold 0.03 min
 1 (±7%) 20-fold
5 bp 0.8 min
 1 (±6%) 360-fold 0.03 min
 1 (±17%) 20-fold
7 bp 1.2 min
 1 (±7%) 540-fold 0.30 min
 1 (±7%) 210-fold
9 bp 3.2 min
 1 (±9%) 1410-fold 0.50 in
 1 (±6%) 450-fold
11 bp 3.1 min
 1 (±13%) 1360-fold 1.00 in
 1 (±15%) 820-fold
13 bp 2.6 min
 1 (±10%) 1140-fold 0.20 min
 1 (±10%) 190-fold
Data are given for the scPvuII-C12–TFO and scPvuII-C6–TFO conjugates that differ in spacer length (12 or 6 methylene groups between the protein and the
oligonucleotide).Cleavagerateconstantsweredeterminedforsixdifferentaddressed239bpsubstratesthatdifferinthespacingbetweenthePvuIIsiteandtheTFS.
SDbasedonthreeindependentexperimentsaregiveninparentheses.Cleavagepreference istheratiooftherateconstantsfortheaddressed(239bp)tounaddressed
(478 bp) substrate.
Nucleic Acids Research, 2005, Vol. 33, No. 22 7043the linear plasmid, was obtained and no further cleavage was
observed even after incubation for several hours. This result
indicates that addressed cleavage of the plasmid is highly
speciﬁc, because only the addressed PvuII site is cleaved
and the four unaddressed sites are unaffected. Highly prefer-
ential addressed site cleavage was also observed with the lin-
ear form of the plasmid and conﬁrmed by cleavage product
analysis (Figure 2). Quantitative intensity analysis of the
various DNA bands yielded cleavage rate constants of the
addressed site in the supercoiled and the linearized plasmid
of 1.4 and 3.9 min
 1, respectively. Cleavage of the other PvuII
sites was not detectable thus demonstrating a >1000-fold
cleavage preference (a conservative estimate considering
the detection limit of the intensity analysis).
Programmed restriction enzymes are intended to be used
for large genome mapping and gene targeting in complex
genomes. To demonstrate that our scPvuII–TFO conjugates
are able to speciﬁcally cleave an addressed PvuII site in a
large excess of unaddressed PvuII sites, we have incubated
0.006 pmol scPvuII-C12-TFO with 0.007 pmol plasmid DNA
(four PvuII sites, one of which having a TFS at a distance of
9 bp) in the presence of 0.68 pmol bacteriophage l-DNA
(15 PvuII sites), corresponding to a 1460-fold excess of
unaddressed PvuII sites over addressed PvuII, and then started
the reaction by addition of MgCl2. Only cleavage at the
addressed site could be detected (Figure 4).
The target site of our programmed restriction enzymes is
a composite site consisting of the PvuII site and the TFS.
The speciﬁcity of the restriction enzyme–TFO conjugate,
Figure 3. Addressed cleavage by scPvuII-C12-TFO of a 5556 bp plasmid.
The plasmid contains five PvuII sites, one of which is flanked by a TFS 9 bp
away. Top: Plasmid DNA (50 nM) was preincubated with scPvuII-C12-TFO
(45 nM) to allow triple-helix formation. After addition of MgCl2 (final con-
centrations:2.5mMMgCl2and100mMNaCl),aliquotsofthereactionmixture
were taken at the time intervals indicated and reaction products analyzed by
agarose gel electrophoresis. The first lane is a cleavage control experiment,
where the supercoiled plasmid was incubated for 5 min with scPvuII-C12-TFO
in cleavagebuffer without priorincubationin theabsenceofMg
2+:underthese
conditions the plasmid is cleaved at its 5 PvuII sites. P and H denote the
(unaddressed) PvuII and HindIII sites, respectively. The addressed PvuII site
is indicated by an open star. Bottom: Addressed cleavage of the same plamid
afterlinearizationwithHindIII.Nowthe5556bpfagmentcarriestheaddressed
site at position 3268.
Figure 4. Addressed cleavage by scPvuII-C12-TFO in the presence of a 1400-
fold excess of unaddressed PvuII sites over addressed PvuII. 0.16 nM
scPvuII-C12-TFO, 0.18 nM plasmid DNA with a single addressed PvuII site
and3PvuIIsitesand17nMl-DNAwith15PvuIIsiteswerepreincubatedinthe
absence of Mg
2+; cleavage was initiated by addition of MgCl2 (final concen-
trations: 2.5 mM MgCl2 and 100 mM NaCl). The reaction products obtained
after the times indicated were analyzed by agarose gel electrophoresis. The gel
on the left shows the result of the control experiment (cleavage without pre-
incubation): a typical PvuII cleavage pattern of bacteriophage l-DNA is seen.
Thegelontherightshowstheresultofthecleavagepatternafterpreincubation:
only the cleavage of plasmid DNA is observed, however not cleavage of
bacteriophage l-DNA.
7044 Nucleic Acids Research, 2005, Vol. 33, No. 22therefore, depends in part on the speciﬁc interaction between
the TFO and the TFS. To see how a single ‘Hoogsteen
mismatch’ in the triple-helix formed upon interaction of the
scPvuII-TFO with the double-stranded DNA substrate affects
the rate of cleavage, a variant of the 239 bp substrate with a
single addressed PvuII site was used, which had instead
of the 50-TTTTTTTCTCTCTCTC-30/50-GAGAGAGAGAAA-
AAAA-30 sequence in 9 bp distance to the PvuII site the
sequence 50-TTTTTTTYTCTCTCTC-30 (Y ¼ A, G or T)/
50-GAGAGAGAXAAAAAAA-30 (X ¼ T, C or A). The sub-
strates with the M.TA ‘Hoogsteen mismatch’ was not cleaved
by the scPvuII-C12-TFO, whereas the substrates with the
M.CG and M.AT ‘Hoogsteen mismatch’ were cleaved by a
factor of at least 100 more slowly than the reference substrate
with no ‘Hoogsteen mismatch’ (M.GC) (Figure 5) indicating
a high sequence speciﬁcity of the addressing process.
DISCUSSION
In principle triple helices can be used to target unique DNA
sequences for biotechnological and biomedical applications
(17,42–55). Of particular interest are conjugates of TFOs
with nucleases, which could be used to cleave DNA in vitro
for genome analysis and in vivo (or ex vivo) for gene replace-
ment by double-strand break repair involving homologous
recombination. We have chosen to extend the speciﬁcity of
REases using TFOs, given the combinatorial ﬂexibility this
fusion offers in addressing a short, yet precisely recognized
restriction site next to a deﬁned TFS. Here, we have produced
a conjugate of the single chain variant of the type II restriction
endonuclease PvuII (scPvuII) (23) with a 16mer oligo-
deoxyribonucleotide containing 5-methyl-20-deoxycytidine
(for deoxycytidine) and 5-[1-propynyl]-20-deoxyuridine (for
thymidine) and characterized its DNA cleavage properties.
The TFO component of this conjugate forms a stable triple-
helix at neutral pH, as was shown before (19) and conﬁrmed
here. The PvuII component binds to DNA non-speciﬁcally in
the absence of Mg
2+, but speciﬁcally in the presence of Mg
2+
(34). Thus, in the absence of Mg
2+ the conjugate will be
directed to the TFS, and only if a PvuII recognition site is
in suitable proximity to the TFS (‘addressed PvuII site’) will
the DNA be cleaved upon addition of Mg
2+. The target site of
the scPvuII–TFO conjugate therefore is a composite of the
PvuII recognition site and the TFS. We have coupled the TFO
to the C-terminus of scPvuII via a (CH2)6o r1 2linker, which
together with the C-terminal His6Gly4Cys-extension of our
scPvuII variant should provide enough ﬂexibility to allow
the scPvuII–TFO conjugate to bind to the PvuII recognition
site after addition of Mg
2+and to cleave the DNA at addressed
PvuII sites in preference over unaddressed sites. These
expectations were borne out by the results of DNA cleavage
experiments, which showed that
i. the scPvuII-C6/C12-TFO conjugate is as active as scPvuII
in cleaving PvuII recognition sites.
ii. the scPvuII-C6/C12-TFO conjugate shows a >1000-fold
preference for addressed over unaddressed PvuII recogni-
tion site, provided that the conjugate is preincubated with
the DNA in the absence of Mg
2+, to allow triple-helix
formation to occur before cleavage.
iii. preferential cleavage is only observed if the enzyme con-
centrationisnotinexcessoveraddressedPvuIIrecognition
sites, because free scPvuII-C6/C12-TFO conjugate would
eventually attack unaddressed PvuII recognition sites.
iv. the preference for cleavage of addressed PvuII recognition
site shows a pronounced Mg
2+ concentration dependence,
little preference at 5 mM (the optimum concentration for
PvuII-catalyzedDNAcleavageisaround5to10mMMg
2+)
and over 1000-fold preference at 1.25 mM Mg
2+
(a sub-optimum concentration for PvuII, but not for the
scPvuII-C6/C12-TFO conjugate, because its binding to
DNA is supported by the TFO–TFS interaction). This pre-
ference is sufficient to cleave DNA at addressed PvuII
recognition sites even in the presence of large amounts
ofunaddressedPvuIIrecognitionsites,astypicallyencoun-
tered in complex genomic DNA.
v. theoptimaldistancebetweenthePvuIIrecognitionsiteand
the TFS for addressed cleavage is  10 bp (a helical turn),
but this distance is less critical for the scPvuII-C12-TFO
conjugate compared to the scPvuII-C6-TFO conjugate,
presumably because of the greater flexibility provided by
the longer linker.
vi. addressed PvuII sites with a single mutation (causing
a ‘Hoogsteen mismatch’) in the TFS are refractory to
cleavage by the scPvuII-C12-TFO conjugate.
Figure5.AddressedcleavagebyscPvuII-C12-TFOofsingle‘Hoogsteenmismatch’substrates.Equimolar(45nM)amountsofunaddressed478bpsubstrate(noTFS)
and addressed 239 bp substrate (having a TFS 9 bp away from the PvuII site) were mixed and preincubated with scPvuII-C12-TFO (40 nM) to allow triple-helix
formation. After addition of MgCl2 (final concentrations: 2.5 mM MgCl2 and 100 mM NaCl), the kinetics of cleavage was determined. Three different ‘Hoogsteen
mismatch’substrateswereused,carryingamismatchfortheHoogsteenbasepairinginthemiddleoftheTFS:insteadofaGCbpwhichwouldformaHoogsteenbp
with5-methylcytosine(M),the‘Hoogsteenmismatch’substrateshadaTA,CGandATbp,respectively.Whereasthecorrectsubstrate(M.GC)wasreadilycleaved,
the M.TA, M.CG and M.AT ‘Hoogsteen mismatch’ substrates were largely refractory to cleavage.
Nucleic Acids Research, 2005, Vol. 33, No. 22 7045We conclude from these results that the scPvuII-C6/C12-TFO
conjugate is able to cleave addressed PvuII sites on high
molecular weight DNA with the speciﬁcity required for
recombinant DNA work and for this purpose could be used
instead of homing endonucleases or other ‘rare cutters’ (e.g.
REase with 8 bp recognition sites). In principle, this or similar
constructs could therefore be used to map chromosomal DNA
and to clone very large DNA fragments. Given the fact that
TFO can be synthesized that would form triple helices
with any sequence that one would like to address (22), the
scPvuII variant can be considered a programmable restriction
enzyme. In addition, there is no reason why this approach
should not work with other restriction enzymes such that
the requirement for the presence of a PvuII recognition
site is not absolute. Furthermore, this approach could in
principle also be used to program other ‘DNA enzymes’,
e.g. DNA-methyltransferases.
It has been shown that highly efﬁcient endogenous human
gene correction can be achieved using targeted DNA cleavage
by a designed nuclease (5,56,57). In this case a designed zinc
ﬁnger nuclease was used, which contained the non-speciﬁc
catalytic domain of the Type IIs REase FokI. We believe
that restriction endonuclease–TFO conjugates are a useful
alternative to designed zinc ﬁnger nucleases, because of
their simple rules of deﬁning TFS sites. That triple-helix
formation can be used to target genes in vivo has been
shown recently (58). To target unique sites in complex gen-
omes in vivo by restriction endonuclease–TFO conjugates
will require efﬁcient delivery systems (59), stabilization of
the TFO by chemical modiﬁcation (17) [or using PNA (60)]
and a procedure to activate the REase [‘caged’ (61) REase]
after triple-helix formation has occurred which all is in
technological reach.
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